As of 2026-09-23, the Relative Valuation of Aerie Pharmaceuticals Inc (AERI) is (20.55) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.25 USD, the upside of Aerie Pharmaceuticals Inc based on Relative Valuation is -234.7%.
The range of the Relative Valuation is (22.78) - (16.27) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 30.8x - 36.7x | 33.8x |
| Forward P/E multiples | 21.6x - 22.0x | 21.8x |
| Fair Price | (22.78) - (16.27) | (20.55) |
| Upside | -249.4% - -206.7% | -234.7% |
| Date | P/E |